370 results on '"Damodaran S"'
Search Results
2. Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2− breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2
3. 33P Antitumor activity of TROP2 antibody drug conjugate datopotamab deruxtecan in chemotherapy-resistant breast cancer models
4. The role of magnetic Reynolds number in MHD forced convection heat transfer
5. Computational approach for transient solution to M/M/1 retrial queue with catastrophe under non-preemptive priority.
6. Indigenous cattle biodiversity in India: Adaptation and conservation
7. IDF21-0598 Remission of T2DM by digital twin technology across Indian and American cohorts – Initial insights from real-world study
8. Remission of T2DM by digital twin technology with reduction of cardiovascular risk: interim results of randomised controlled clinical trial
9. On the Shifted Hybrid Log-Normal Distribution
10. LBA4 Datopotamab deruxtecan (Dato-DXd), a TROP2-directed antibody-drug conjugate (ADC), for triple-negative breast cancer (TNBC): Preliminary results from an ongoing phase I trial
11. Buckling investigations on a nuclear reactor inner vessel model
12. A case of tubulointerstitial nephritis and uveitis (TINU) syndrome
13. Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension
14. 98O The immunomodulatory (IM) signature enhances prediction of pathologic complete response (pCR) to neoadjuvant therapy (NAT) in triple negative breast cancers (TNBC) with moderate stromal tumour infiltrating lymphocytes (sTIL)
15. Computational approach to Transient solution for single unreliable server Retrial Queue under non-preemptive priority.
16. OXIDATION OF FOOD COMPONENTS
17. Working Towards a Shared Vision on Development Studies in India and The Netherlands
18. Biopolymer-Biopolymer Interactions at Interfaces and Their Impact on Food Colloid Stability
19. Characteristics, diagnoses, illness course and risk profiles of inpatients admitted for at least 21 days to an Australian private psychiatric hospital.
20. A Novel Zero-Truncated Katz Distribution by the Lagrange Expansion of the Second Kind with Associated Inferences
21. Molecular Bases of Surface Activity of Proteins
22. Empowering MSMEs Through Digital Lending
23. Bintrafusp alfa (M7824) and eribulin mesylate in treating patients with metastatic triple negative breast cancer (TNBC)(NCT03579472)
24. Abstract P1-18-04: CTCs and SUV to predict the efficacy of the bone-specific radiopharmaceutical agent radium-223 dichloride combined with hormonal therapy for hormone receptor-positive bone-dominant breast cancer metastasis
25. Abstract OT1-03-04: INTERACT- INTegrated Evaluation of Resistance and Actionability using Circulating Tumor DNA in hormone receptor (HR) positive metastatic breast cancers (MBC)
26. Abstract P1-15-06: Impact of serial biopsies in triple-negative breast cancer patients receiving neoadjuvant systemic therapy
27. FAK auto-phosphorylation site tyrosine 397 is required for development but dispensable for normal skin homeostasis
28. Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension.
29. A Novel Flexible Class of Intervened Poisson Distribution by Lagrangian Approach
30. Differential expression of interferon‐induced genes and other tissue‐based biomarkers in acute graft‐versus‐host disease vs. lupus erythematosus in skin
31. Impact of clinical, morphologic and molecular characteristics on response to neoadjuvant systemic therapy (NAST) in metaplastic breast cancer (MpBC)
32. Neoadjuvant trial of nab-paclitaxel and atezolizumab (Atezo), a PD-L1 inhibitor, in patients (pts) with chemo-insensitive triple negative breast cancer (TNBC)
33. Abstract P1-16-02: Phase II study of the feasibility and safety of radium-223 dichloride in combination with hormonal therapy and denosumab for the treatment of patients with hormone receptor-positive breast cancer with bone-dominant metastasis
34. Abstract P6-03-05: Risk of needle-track seeding with serial ultrasound guided biopsies in triple negative breast cancer
35. Abstract P1-07-22: Androgen receptor positivity is associated with nodal disease in triple negative breast cancer
36. A Novel Generalization of Zero-Truncated Binomial Distribution by Lagrangian Approach with Applications for the COVID-19 Pandemic
37. Structural stability effects on T4 lysozyme adsorption at the air–water interface
38. Myosin-1E interacts with FAK proline-rich region 1 to induce fibronectin-type matrix
39. A phase II trial of mirvetuximab soravtansine in patients with localized triple-negative breast cancer (TNBC) with tumors predicted insensitive to standard neoadjuvant chemotherapy (NACT) including a lead-in cohort to establish activity in patients with metastatic TNBC
40. Extraction and Utilization of Pure Niobium and Tantalum from Indian Ores
41. Differential expression of interferon‐induced genes and other tissue‐based biomarkers in acute graft‐versus‐host disease vs. lupus erythematosus in skin.
42. 383TiP - Bintrafusp alfa (M7824) and eribulin mesylate in treating patients with metastatic triple negative breast cancer (TNBC)(NCT03579472)
43. Bivariate Discrete Modified Weibull (BDMW) Distribution
44. Study of Heat Transfer Control with Magnetic Field Using Higher Order Finite Difference Scheme
45. 228P - Impact of clinical, morphologic and molecular characteristics on response to neoadjuvant systemic therapy (NAST) in metaplastic breast cancer (MpBC)
46. 224P - Neoadjuvant trial of nab-paclitaxel and atezolizumab (Atezo), a PD-L1 inhibitor, in patients (pts) with chemo-insensitive triple negative breast cancer (TNBC)
47. Observations on the wilt disease of the Banana
48. Monitoring of transitions in multi-grade continuous processes
49. Desynchronization of Fast-Spiking Interneurons Reduces -Band Oscillations and Imbalance in Firing in the Dopamine-Depleted Striatum
50. 320TiP - A phase II trial of mirvetuximab soravtansine in patients with localized triple-negative breast cancer (TNBC) with tumors predicted insensitive to standard neoadjuvant chemotherapy (NACT) including a lead-in cohort to establish activity in patients with metastatic TNBC
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.